Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-12-28 Sale | 2023-12-29 4:35 pm | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 84,000 | $4.7131 | $395,900 | 1,283,674 (Direct) | View |
2021-12-08 Purchase | 2021-12-08 2:41 pm | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 6,500 | $1.0599 | $6,889 | 383,672 (Direct) | View |
2021-12-02 Purchase | 2021-12-02 12:28 pm | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 10,000 | $1.0954 | $10,954 | 377,172 (Direct) | View |
2021-11-18 Purchase | 2021-11-22 11:42 am | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 22,150 | $1.1011 | $24,390 | 367,172 (Direct) | View |
2021-08-17 Purchase | 2021-08-18 4:03 pm | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 26,900 | $1.1846 | $31,866 | 345,022 (Direct) | View |
2021-05-21 Purchase | 2021-05-24 08:10 am | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 10,000 | $1.6298 | $16,298 | 318,122 (Direct) | View |
2021-04-19 Purchase | 2021-04-19 2:46 pm | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 27,400 | $1.8201 | $49,871 | 308,122 (Direct) | View |
2021-03-22 Purchase | 2021-03-22 9:47 pm | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 24,100 | $2.0721 | $49,938 | 280,722 (Direct) | View |
2021-02-22 Purchase | 2021-02-23 09:48 am | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 28,700 | $1.7435 | $50,038 | 256,622 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-06 Option Award | 2024-06-10 8:50 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Pauls Matthew Director | 6,500 | $0 | 6,500 (Direct) | View |
2023-12-28 Gift | 2023-12-29 4:35 pm | N/A N/A | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 19,000 | $0 | 1,283,674 (Direct) | View |
2023-12-14 Option Award | 2023-12-15 5:46 pm | N/A 2033-12-14 | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 675,000 | $0 | 1,611,674 (Direct) | View |
2023-12-14 Tax Withholding | 2023-12-15 5:46 pm | N/A N/A | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 109,680 | $4.45 | 1,611,674 (Direct) | View |
2023-08-15 Option Award | 2023-08-16 4:13 pm | N/A 2033-08-15 | SOLENO THERAPEUTICS INC | SLNO | Pauls Matthew Director | 15,000 | $0 | 15,000 (Direct) | View |
2022-12-13 Option Award | 2022-12-15 4:06 pm | N/A 2032-12-13 | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 1,025,000 | $0 | 1,746,354 (Direct) | View |
2021-12-31 Tax Withholding | 2022-01-03 4:10 pm | N/A N/A | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 62,318 | $1.24 | 721,354 (Direct) | View |
2021-12-14 Option Award | 2021-12-14 6:31 pm | N/A 2031-12-14 | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 750,000 | $0 | 1,133,672 (Direct) | View |
2020-12-16 Option Award | 2020-12-17 12:34 pm | N/A 2030-12-16 | Savara Inc | SVRA | Pauls Matthew CHIEF EXECUTIVE OFFICER | 500,000 | $0 | 500,000 (Direct) | View |
2020-05-20 Disposition | 2020-05-21 4:31 pm | N/A N/A | Zyla Life Sciences | ZCOR | Pauls Matthew Director | 26,953 | $0 | 0 (Direct) | View |
2020-04-23 Exercise(A) | 2020-04-28 7:39 pm | N/A N/A | Zyla Life Sciences | ZCOR | Pauls Matthew Director | 6,667 | $1.75 | 18,195 (Direct) | View |
2020-04-23 Tax Withholding(A) | 2020-04-28 7:39 pm | N/A N/A | Zyla Life Sciences | ZCOR | Pauls Matthew Director | 1,805 | $1.75 | 18,195 (Direct) | View |
2020-04-23 Exercise(A) | 2020-04-28 7:39 pm | N/A N/A | Zyla Life Sciences | ZCOR | Pauls Matthew Director | 6,667 | $0 | 18,195 (Direct) | View |
2020-04-23 Exercise | 2020-04-24 6:12 pm | N/A N/A | Zyla Life Sciences | ZCOR | Pauls Matthew Director | 6,667 | $1.75 | 19,048 (Direct) | View |
2020-04-23 Tax Withholding | 2020-04-24 6:12 pm | N/A N/A | Zyla Life Sciences | ZCOR | Pauls Matthew Director | 952 | $1.75 | 19,048 (Direct) | View |
2020-04-23 Exercise | 2020-04-24 6:12 pm | N/A N/A | Zyla Life Sciences | ZCOR | Pauls Matthew Director | 6,667 | $0 | 19,048 (Direct) | View |
2020-03-04 Option Award | 2020-03-05 8:41 pm | N/A N/A | Zyla Life Sciences | ZCOR | Pauls Matthew Director | 13,620 | $0 | 13,620 (Direct) | View |
2019-12-20 Option Award | 2019-12-26 6:03 pm | N/A 2029-12-20 | Savara Inc | SVRA | Pauls Matthew Director | 12,000 | $0 | 12,000 (Direct) | View |